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Abstract
Background: The V3 loop of the glycoprotein gp120 of HIV-1 plays an important role in viral entry into cells by
utilizing as coreceptor CCR5 or CXCR4, and is implicated in the phenotypic tropisms of HIV viruses. It has been
hypothesized that the interaction between the V3 loop and CCR5 or CXCR4 is mediated by electrostatics. We have
performed hierarchical clustering analysis of the spatial distributions of electrostatic potentials and charges of V3
loop structures containing consensus sequences of HIV-1 subtypes.
Results: Although the majority of consensus sequences have a net charge of +3, the spatial distribution of their
electrostatic potentials and charges may be a discriminating factor for binding and infectivity. This is demonstrated
by the formation of several small subclusters, within major clusters, which indicates common origin but distinct
spatial details of electrostatic properties. Some of this information may be present, in a coarse manner, in clustering
of sequences, but the spatial details are largely lost. We show the effect of ionic strength on clustering of
electrostatic potentials, information that is not present in clustering of charges or sequences. We also make
correlations between clustering of electrostatic potentials and net charge, coreceptor selectivity, global prevalence,
and geographic distribution. Finally, we interpret coreceptor selectivity based on the N
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glycosylation motif, the specific positive charge location according to the 11/24/25 rule, and the overall charge and
electrostatic potential distribution.
Conclusions: We propose that in addition to the sequence and the net charge of the V3 loop of each subtype,
the spatial distributions of electrostatic potentials and charges may also be important factors for receptor
recognition and binding and subsequent viral entry into cells. This implies that the overall electrostatic potential is
responsible for long-range recognition of the V3 loop with coreceptors CCR5/CXCR4, whereas the charge
distribution contributes to the specific short-range interactions responsible for the formation of the bound
complex. We also propose a scheme for coreceptor selectivity based on the sequence glycosylation motif, the 11/
24/25 rule, and net charge.
Keywords: HIV-1, protein-receptor interactions, Poisson-Boltzmann electrostatics, electrostatic similarity distance,
electrostatic clustering
Background
HIV-1 entry into the host cell is mediated by the viral
envelope glycoprotein gp120 associated with gp41 and
involves on the host cell surface the CD4 molecule
together with the CCR5 or CXCR4 receptor [1,2]. Upon
CD4 binding, a conformational change is induced in
gp120, exposing a region that can interact with CCR5 or
CXCR4 [2]. CCR5 and CXCR4 belong to the chemokine
receptor family, which is part of the G-protein couple
receptor (GPCR) superfamily, a large group of mem-
brane proteins characterized by seven transmembrane
a-helices and four extracellular and four intracellular
domains. CD4 binding also can induce further confor-
mational changes in the envelope glycoprotein, exposing
a glycine rich region of gp41 which is involved in mem-
brane fusion [3,4].
The envelope glycoprotein gp120 is composed of 400-
410 amino acids including 5 variable regions (V1-V5)
[2,5,6]. The third variable region of gp120 forms a loop,
called the V3 loop, and is composed of 31-39 amino
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formed by two cysteines and is positively charged. It
consists of three distinct regions: the base (closer to the
core of the protein), the tip at the opposite end, and the
stem between the base and the tip. The V3 loop is
implicated in the phenotypic tropisms of HIV viruses,
playing an important role in viral entry by utilizing as
coreceptor CCR5 or CXCR4. Viruses utilizing CCR5 are
referred to as R5 and are preferentially transmitted,
whereas those utilizing CXCR4 are associated with dis-
ease progression and are referred to as X4. Considering
that HIV viruses undergo mutations at very high rates,
it is not unusual for several variants to exist in a given
patient sample [7,8].
It has been suggested that when amino acids at posi-
tions 11 and/or 25 of the V3 loop are positively charged,
the virus shows preference for selecting CXCR4 as core-
ceptor, and when the amino acid at position 11 is
uncharged or negatively charged and at position 25 is
negatively charged, the virus shows preference for CCR5
coreceptor [8-12]. This means that charge switch to
positive at positions 11 or 25 suggests switch of core-
ceptor selection to CXCR4. It has also been suggested
that, besides amino acids 11 and 25, amino acid 24 is
also involved in coreceptor selection, with the proposi-
tion of the so-called “11/24/25” rule [12]. This rule
states that positively charged amino acids at one or
more of positions 11, 24 or 25 suggest an X4 virus.
The V3 loop is solvent exposed, highly charged, and
highly dynamic. Its dynamic character is indicated by
the fact that the V3 loop is absent in many crystallo-
graphic structures because of lack of resolved electron
density. In two available crystallographic structures in
which gp120 is stabilized because of multicomponent
complex formation, the V3 loop is structurally resolved
but with different secondary structure content ([3,6];
Figure 1). Several studies have demonstrated that the V3
loop interacts with the N-terminal extra-cellular domain
of CCR5 (CCR5-Nt) and the extracellular loop 2 (ECL2)
[6]. Post-translational modifications by the addition of
sulfate groups in two or three of the tyrosines of CCR5-
Nt have been shown to be essential in the interaction
with gp120 [13-15]. The physicochemical mechanism of
the gp120:CCR5 interaction is not well understood. Ear-
lier studies have proposed that the interaction between
CCR5-Nt and V3 loop is driven by electrostatics,
between a highly positive V3 loop and a highly negative
CCR5-Nt [16-19]. We have previously proposed a corre-
lation between the strength of electrostatic potential
with binding affinities and inhibitory activities for sev-
eral V3 loop-derived peptides [18]. Another study of V3
loop chimeras has shown that their ability to bind CCR5
is affected by the amino acid composition and charge
[11].
The diversity of HIV-1 presents a major challenge in
the development of effective treatments. Currently, HIV-
1 strains are divided into three distinct genetic groups:
M (major), N (non-major, non-outlier), and O (outlier),
with variants within group M being responsible for the
majority of the infected population. This group is
further divided based on the sequence variability of its
env and gag genes [7] into ten subtypes or clades,
named A through K, and circulation recombinant forms
(CRFs). Differences in coreceptor usage, geographical
distribution and global prevalence have been demon-
strated for several of the identified subtypes [19-22].
In this study we have modeled the V3 loop of several
HIV-1 subtypes using the available two crystal struc-
tures with intact V3 loop as templates [3,6] and consen-
sus sequences, which were obtained from the HIV
Databases of the Los Alamos National Laboratory [23].
We have performed computational studies to cluster the
various subtypes according to similarities of the spatial
distributions of their electrostatic potentials and the spa-
tial distributions of their charges. The spatial distribu-
tions of individual charges are responsible for generating
the spatial distributions of electrostatic potentials, while
taking into account dielectric and ionic screening. We
have analyzed the resulting clusters to determine corre-
lations between the electrostatic potential distributions
and charge distributions with net charge, epidemiologi-
cal data such as global prevalence and geographical dis-
tribution, and coreceptor selection. We have also
generated sequence alignment and sequence similarity
clusters for all the V3 loop subtypes. Our goal was to
perform a clustering analysis of the gp120 V3 loop of
HIV-1 at various levels of refinement, based on
sequence, net charge, and spatial distribution of electro-
static potential and charge. The electrostatic clustering
analysis may be useful in much-needed vaccine, vaccine
adjuvant, or inhibitor design against HIV-1 infection
[24-26].
Methods
Our computational framework AESOP (Analysis of Elec-
trostatic Potentials Of Proteins) [27-31] was used to
generate theoretical structures of several V3 loop sub-
types, to calculate electrostatic potentials, and to cluster
their respective spatial distributions of electrostatic
potentials. We have also performed clustering analysis
of V3 loop subtypes according to their charge distribu-
tions and sequence similarities.
V3 loop structural templates
We used the coordinates of two Protein Data Bank
(PDB [32]) files in which the V3 loop was intact, as
structural templates. The PDB codes are 2B4C[5] and
2QAD [6], both from subtype B. In 2B4C, the gp120
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terminal two-domain fragment) and the antigen-binding
fragment (Fab) of the X5 antibody. In 2QAD, gp120 was
in complex with CD4 and a functionally sulfated anti-
body, 412d. From both structures, we have retained only
the coordinates of the V3 loop for our study. The V3
loop in both structures starts at position 296 and ends
at position 331. In the case of 2B4C four amino acids
have double conformations, from which conformation A
was retained. In both structures amino acids 310-311
are missing while two amino acids occupy position 322.
We have renumbered the atoms and amino acids start-
ing from position 1 and ending in position 35, using
Swiss-PDB Viewer (SPDBV, [33]).
V3 loop subtype consensus sequences
HIV-1 sequences are deposited in the HIV Databases of
the Los Alamos National Laboratory [[23]; http://www.
hiv.lanl.gov]. Using tools within the database we
extracted consensus sequences for the V3 loop of HIV-
1. For our study, we isolated the amino acid sequences
between and including the first and last cysteines of the
V3 loop. The Sequence Search Interface Tool was first
used to obtain nucleotide sequences for HIV-1 subtypes.
Within this search tool, the parameters selected were:
subtype (for example, subtype A), virus (HIV-1), and
genomic region (V3). The search result file is the input
file for the ElimDupes tool, which compares all the
sequences and eliminates any duplicates. A cutoff of
Figure 1 Molecular models of the V3 loop. (A) Stick representation of backbone and side chains using the gp120 structure with PDB Code
2QAD. (B) Ribbon representation of backbone using the structure with PDB Code 2QAD. (C) Stick representation of backbone and side chains
using the gp120 structure with PDB Code 2B4C. (D) Ribbon representation of backbone using the gp120 structure with PDB Code 2B4C. The
color code for (A) and (C) is: blue, positively charged; red, negatively charged; green, polar; gray, nonpolar. The color code for (B) and (D) is
according to secondary structure. Images were generated using VMD [78].
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The unique sequences file was used as the input file for
the HIValign tool, which aligns the sequences based on
curated alignments within the database using the Hid-
den Markov Model (HMM) method. Several options
were selected for this tool: align the sequences by
HMM, codon-align the sequences, and translate to
amino acid. The Simple Consensus Maker tool was then
used to obtain a consensus sequence, with the resulting
file from HIValign being used as the input file. The
default parameters were kept, resulting in an alignment
sequence with the first sequence identified as the
consensus.
This procedure was done for each subtype and groups
N and O and the results of consensus sequence align-
ment are shown in Table 1. Subtype A includes sub-
subtypes A1 and A2, subtype F includes sub-subtypes
F1 and F2, and subtype CPX includes the 11 cpx sub-
types available in the database. The consensus for sub-
type D resulted in 33 amino acid sequence, because of
gaps at positions 24-25. To equalize the length of the D
subtype with the 35-amino acid length of the rest of the
subtypes, we calculated amino acid frequencies at posi-
tions 24-25 of the D subtype and chose the amino acids
with the second highest frequency in the alignments
(gaps being the highest frequency). These amino acids
were lysine at position 24 and asparagine at position 25
(Table 1). Subtype J and group O contained two amino
acids with the exact same frequency at a particular loca-
tion. In the case of subtype J, the amino acids where iso-
leucine and leucine; and for group O, the amino acid
was glutamic acid and a gap (introduced by the align-
ment). For subtype J, isoleucine was selected and for
group O, glutamic acid was selected. Subtypes B and K
have the same consensus sequences, and subtypes CPX
and H also share identical consensus sequences. Sub-
types AB, AE, AG, and CPX are circulating recombinant
forms (CRFs).
The program Modeller [9v6, 34] was used to create
homology models of all subtypes, using the two crystal
structures as templates, with the modifications described
above. The default optimization and refinement protocol
of Modeller was used to generate single models, opti-
mized with conjugate gradients and molecular
dynamics-based simulated annealing.
Clustering of electrostatic potentials
The use of similarity measures for clustering of electro-
static (and other physicochemical) properties is a topic
of chemistry and drug design research [35-38]. Cluster-
ing of electrostatic potentials of protein families has
been introduced by Wade and coworkers [39-45],
including software tools under the name PIPSA
[39,40,43,44], and subsequently used or extended by
others, including our group [27-31,46-51]. This type of
analysis depicts electrostatic similarities of proteins,
which can be correlated to biological properties and
functions. For our analysis we used the AESOP compu-
tational framework [27-31], which provides a platform
for elucidating the role of electrostatics, and more speci-
fically the role of ionizable amino acids, in protein asso-
ciation. This is accomplished using theoretical alanine
scan or other mutagenesis, in which electrostatic prop-
erties are perturbed by systematically removing ionizable
amino acids [27-31,48,49,51]. The effects of these per-
turbations are then quantified through the use of elec-
trostatic similarity clustering and electrostatic free
energies of association, to give insights into the contri-
butions of ionizable amino acids in both recognition
and binding [27,28,30,31,48,49,51]. Since electrostatics is
also known to be an important aspect of protein
dynamics and evolution, AESOP also has utilities for
analyzing the electrostatics of molecular dynamics tra-
jectories [28] and homologous proteins/protein domains
[31,47,50].
Poisson-Boltzmann electrostatic calculations and hier-
archical clustering analysis were performed as described
elsewhere [27-30]. The program PDB2PQR [52] was
used to prepare the V3 loop coordinates for electrostatic
Table 1 Alignment of the year 2009 consensus sequences
of the V3 loop.
Subtype Sequence Charge
123456789012345678901234567890123456
2B4C CTRPNQNTRKSIHIGPGRAFYTTG-EIIGDIRQAHC 3
2QAD CTRPNNNTRKSINIGPGRALYTTG-EIIGDIRQAHC 3
A CTRPNNNTRKSVRIGPGQAFYATG-DIIGDIRQAHC 3
AB CIRPGNNTRTSIRIGPGQTFYATG-DVIGDIRQAHC 2
AE CTRPSNNTRTSITIGPGQVFYRTG-DIIGDIRKAYC 3
AG CTRPNNNTRKSVRIGPGQTFYATG-DIIGDIRQAHC 3
B CTRPNNNTRKSIHIGPGRAFYATG-DIIGDIRQAHC 3
C CTRPNNNTRKSIRIGPGQTFYATG-DIIGDIRQAHC 3
CPX CTRPNNNTRKSIHIGPGQAFYATG-DIIGDIRQAHC 2
D CTRPYNNTRQSTHIGPGQALYTT—IIGDIRQAHC 2
D35 CTRPYNNTRQSTHIGPGQALYTTK-NIIGDIRQAHC 3
F CTRPNNNTRKSIHLGPGQAFYATG-DIIGDIRKAHC 3
G CTRPNNNTRKSIRIGPGQAFYATG-DIIGDIRQAHC 3
H CTRPNNNTRKSIHIGPGQAFYATG-DIIGDIRQAHC 2
J CIRPANNTRKGIHIGPGQVLYATG-EIIGDIRQAHC 2
K CTRPNNNTRKSIHIGPGRAFYATG-DIIGDIRQAHC 3
N CTRPGNNTGGQVQIGPAMTFYNIE-KIVGDIRQAHC 1
O CERPGNNTVQEIKIGP-MAWYSMGLEENNNSRAAYC -1
V3 loop subtype consensus sequences were obtained using the tools available
within the Los Alamos National Laboratory Database ([23]; http://www.hiv.lanl.
gov), except for sequences 2B4C and 2QAD, which are from the crystal
structures deposited at the PDB. Some subtype consensus sequences were
identical: CPX with H, and B with K. Subtypes AB, AE, AG, and CPX are
circulating recombinant forms (CRFs). The construction of D35 from D is
described in Methods. Gaps are introduced by the alignment.
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charges for all atoms according to the PARSE forcefield
[53]. Electrostatic potentials were calculated using the
Adaptive Poisson Boltzmann Solver (APBS [54]) and the
linearized form of the Poisson-Boltzmann equation. A
box with 129 × 129 × 129 grid points was used. The
b o xd i m e n s i o n sw e r e :7 0Å×7 0Å×7 5Åa n d5 0Å×
50 Å × 55 Å for 0 and 150 mM, respectively, for sub-
types from the template 2B4C; and 60 Å × 70 Å × 75 Å
and 50 Å × 50 Å × 50 Å for 0 and 150 mM, respec-
tively, for subtypes from thet e m p l a t e2 Q A D .D i f f e r e n t
box sizes were used for 0 mM and 150 mM calculations
to assure maximum resolution while including optimal
number of grid points with electrostatic potential values
within and about ± 1 kBT/e. The molecular surface was
calculated using a probe sphere with a radius of 1.4 Å,
representing a water molecule. The dielectric coeffi-
cients were set to 2 and 78.54 for the protein interior
and solvent, respectively. The ion accessibility surface
was calculated using a probe sphere with radius of 2.0
Å, representing monovalent counterions. Calculations
were repeated with ionic strengths corresponding to 0
mM salt concentration (representing Coulombic interac-
tions unscreened by counterions) and 150 mM (repre-
senting physiological ionic strength in serum). A total of
36 calculations were performed for the consensus
sequence structures generated from each of the two
templates and for the template (crystal) structures.
Electrostatic similarity distances (ESDs) were calcu-
lated according to
ESDa,b =
1
N

i,j,k
 a(i,j,k) − b(i,j,k)
 
max
 a(i,j,k)
 ,
 b(i,j,k)
  (1)
where Fa and Fb are the electrostatic potentials of
proteins a and b at grid point (i, j, k) and N is the total
number of grid points. This error-type relation com-
pares the spatial distributions of electrostatic potentials
of pairs of proteins. A matrix of 18 × 18 ESDs was cre-
ated corresponding to the HIV-1 subtype structures.
The normalization factor of the denominator assures
small values in the vicinity of the 0-2 range, with 0 cor-
responding to identical spatial distributions of electro-
static potentials and 2 to totally different. Four matrices
were constructed for two sets of structures (from two
templates), with electrostatic potentials calculated at two
ionic strength values. Each matrix was analyzed sepa-
rately. Visualization of the spatial distributions of elec-
trostatic potentials, as isopotential contour surfaces, was
accomplished using the program Chimera [55].
The ESD shown above was also applied to cluster sub-
type sequences based on charge distribution maps using
APBS. Hierarchical clustering analysis was performed
using the hclust function of R. The clustered data were
plotted as dendrograms using the language and statisti-
cal computing environment R (Foundation for Statistical
Computing: Vienna, Austria, 2009. http://www.R-pro-
ject.org).
Clustering of subtype sequences
Alignment for all HIV-1 subtype sequences of Table 1
was performed using ClustalW2 [56]. The score matrix
g e n e r a t e db yC l u s t a l W 2w a su s e da st h ei n p u td i s t a n c e
file to create a clustering dendrogram using the linkage
function of MatLab (The MathWorks Inc., Natick, MA).
Results and discussion
Importance of V3 loop variability and charges for viral
infection
HIV is characterized by its ability to frequently mutate
as evidenced by the large number of different isolates
and by sequence diversity. A variability “hotspot” is the
V3 loop which is implicated in a number of important
functions including coreceptor usage during cell entry.
Despite its hypervariable nature, V3 retains a basic func-
tion, that to interact and to modulate its preferential
usage of CCR5 and CXCR4, a crucial step in the process
of infection and indeed for the survival of the virus
[57,58]. With this in mind, we attempted in the present
investigation to address the contrasting function of V3,
that of the frequent mutations necessary to evade host
immune responses, and at the same time to retain the
required interaction with coreceptors on the host cell.
In this respect, we explored the combined electrostatic
potentials of the amino acids in the V3 loop and their
distribution in all HIV-1 subtypes, for which the tropism
and V3 amino acid sequence are known, in order to
exploit canonical rules that might exist.
We have performed electrostatic potential calculations
of the gp120 V3 loops, using the Poisson-Boltzmann
method [59] and clustering analysis [60] of the spatial
distributions of electrostatic potentials for several HIV-1
subtypes. The clustering analysis allows the classification
of similarities/dissimilarities of the subtypes based on
the common property of electrostatic potentials. Electro-
static interaction is expected because, typically, the V3
l o o ph a sa ne x c e s so fp o s i t i v ec h a r g ea n dt h ep u t a t i v e
interacting N-terminal domain of the coreceptor CCR5,
and to a lesser extent CXCR4, has an excess of negative
charge. We have performed similar clustering analysis
for the spatial distributions of charges and for sequence
similarities of HIV-1 subtypes. It is actually the property
of charge that many researchers have investigated to
shed light into the V3 loop-CCR5/CXCR4 interaction.
For example, a recent study has proposed that positively
charged amino acids at positions 11, 24 and 25 are
involved in coreceptor selection and binding (the “11/
24/25” rule [12]). In our study we present an analysis
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V3 loops from various subtypes, but also incorporates
the more detailed information that is hidden within the
spatial distributions of electrostatic potentials. It is actu-
ally the electrostatic potential that is responsible for
recognition of two proteins if they have excess of oppo-
site net charges. Recognition, which in our protein-pro-
tein interaction model refers to the formation of a weak
and nonspecific encounter complex, is followed by bind-
ing, which is the formation of the specific final complex
[27-30,61-69]. Although the origin of the electrostatic
potential is unit and partial charges located in the pro-
tein surface and interior, the protein net charge does
not capture the effect of charge distribution on protein-
protein interactions. It is the spatial distributions of
electrostatic potentials of two proteins that mediate
long-range electrostatic interactions and protein-protein
recognition. It is also the spatial distributions of charges
of the two proteins that participate in mediating short-
range charge-charge (salt bridging or weak Coulombic
effects) and charge-dipole or dipole-dipole (hydrogen
bonding) interactions and the formation of the final pro-
tein complex. The underlying hypothesis is described by
the following transitive argument: if the electrostatic
potentials and charges mediate protein-protein associa-
tion, and if association mediates viral entry, we can
deduce correlations to virulence by studying the specific
properties of electrostatic potentials and charges, such
as type (positive/negative), strength, and spatial distribu-
tions. These types of correlations are indications of
where to look for causalities and may be helpful in pre-
dicting viral attributes.
Clustering of electrostatic potentials, charges, and
sequences
Figure 2 shows the dendrogram that clusters the calcu-
lated spatial distributions of V3 loop electrostatic poten-
tials. These calculations were performed using 0 mM
ionic strength, depicting largest magnitude of Coulom-
bic interactions within each structure which are
unscreened by solvent ions. The calculations were per-
formed using homology model structures derived from
the crystallographic structure of gp120 with PDB Code
2QAD and the HIV-1 subtype consensus sequences
available in the year 2009 at the HIV Databases of the
Los Alamos National Laboratory (Table 1). Clustering
has been performed by pairwise comparison of the elec-
trostatic potentials of all subtypes listed in Table 1, as
described in Methods. V3 loop subtypes with similar
spatial distribution of electrostatic potential cluster
together. The V3 loops studied have positive net charge,
with the exception of group O, which has -1 net charge
(Figure 2). The predominant net charge is +3, appearing
in 9 subtypes (A, AE, AG, B, C, D35, G, F, K) and in
the sequences of the two crystal structures, 2QAD and
2B4C, which belong to subtype B (Figure 2). From the
remaining subtypes, group N has a net charge of +1 and
A B ,D ,H ,J ,a n dC P Xh a v en e tc h a r g eo f+ 2( F i g u r e2 ) .
Although subtypes with the same net charge cluster
together, there are finer subclusters for subtypes that
discriminate according to the spatial distribution of elec-
trostatic potentials. For example, from the +2 subtypes:
AB and J cluster together; H and CPX cluster together
(they are identical); and D clusters on its own. Overall,
the +2 subtypes form the following cluster (with sub-
clusters in brackets/parentheses): {[(J, AB), (H, CPX)],
D} (Figure 2). Similarly, the +3 subtypes form the fol-
lowing cluster: {[(((G, AG), (K, B)), (2QAD, 2B4C), C),
A], [(F, AE), D35]} (Figure 2). The +2/+3 subtypes form
a supercluster together. The +1 group N clusters on its
own and forms a larger supercluster with the +2/+3
subtypes, whereas the -1 group O clusters entirely on its
own (Figure 2).
In a dendrogram, generated with the more realistic
electrostatic potential calculations using 150 mM ionic
strength (corresponding to physiological ionic strength
in serum), we observe similar overall clustering with
local variations (Figure 3). For example, the +3 subtypes
form the following cluster (with subclusters in brackets/
p a r e n t h e s e s ) :{ [ ( F ,A E ) ,( D 3 5 ,A ) ] ,[ ( ( G ,A G ) ,( K ,B ) ) ,
(2QAD, 2B4C)], C}. The +2 subtypes form individual
clusters (D), (H, CPX), and (J, AB) within the +2/+3
supercluster. The +1 group N clusters on its own and
forms a larger supercluster with the +2/+3 subtypes,
whereas the -1 group O clusters entirely on its own
(Figure 3). Coulombic interactions within the V3 loops
are screened by solvent ions, which results in less
obvious differences in the spatial distributions of elec-
trostatic potentials when inspected visually (e.g., com-
pare isopotential contours of Figure 3 to Figure 2).
Nevertheless, we observe persistent electrostatic cluster-
ing patterns for the various subtypes, despite differences
in their V3 loop sequences.
The clustering of the distribution of charges in space
for each subtype is shown in Figure 4. Some clusters
within this dendrogram can be found in Figures 2 and 3
(e.g., H and CPX). However, the subtypes are mostly
mixed within the +1/+2/+3 supercluster. In general,
charge distribution does not depict subtle differences
between the subtypes. This is because charges are loca-
lized in the structure and are independent from each
other. However, electrostatic potentials, generated by
these charges, have additional features. First, electro-
static potentials account for dielectric and ionic screen-
ing. Because of the latter, we observe differences in the
magnitudes and shapes of electrostatic potentials in Fig-
ures 2 and 3. Second, electrostatic potentials account for
spatial enhancements (additive effect of potentials with
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Page 6 of 16Figure 2 Electrostatic clustering analysis of the HIV-1 subtypes, using the year 2009 consensus sequences and structural template
derived from the gp120 structure with PDB Code 2QAD. The horizontal axis of the dendrogram represents electrostatic similarity distance.
Electrostatic potentials were calculated using ionic strength corresponding to 0 mM salt concentration. Isopotential contours are presented in
four different orientations, corresponding to rotations about the vertical axis (indicated in the figure). Isopotential contours are plotted at ± 1
kBT/e, with blue and red corresponding to positive and negative electrostatic potentials, respectively. The net charge, global prevalence,
geographic distribution, and coreceptor selectivity are indicated in the figure for each subtype. N/A denotes that information was not available.
The orange boxes highlight clusters with HIV-1 subtypes that have similar electrostatic potential and same charge. Green circles in the branches
of the dendrogram denote intersection points between net charges or infected population. The symbol # refers to the global prevalence of
Subtype D, which includes D and D35 combined.
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Page 7 of 16Figure 3 Electrostatic clustering analysis of the HIV-1 subtypes, using the year 2009 consensus sequences and structural template
derived from the gp120 structure with PDB Code 2QAD. The horizontal axis of the dendrogram represents electrostatic similarity distance.
Electrostatic potentials were calculated using ionic strength corresponding to 150 mM salt concentration. Isopotential contours are presented in
four different orientations, corresponding to rotations about the vertical axis (indicated in the figure). Isopotential contours are plotted at ± 1
kBT/e, with blue and red corresponding to positive and negative electrostatic potentials, respectively. The orange box highlights clusters with
HIV-1 subtypes that have similar electrostatic potential and same charge. Green circles in the branches of the dendrogram denote intersection
points between net charges or infected population.
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Page 8 of 16same signs) or spatial cancellations (subtractive effect of
potentials with opposite signs).
Figure 5 shows clustering of the sequences of the
gp120 V3 loops from the subtypes used to generate the
data of Figures 2 and 3. This dendrogram does not, in
general, depict the charge or the electrostatic potential
differences of the various V3 loops. Obvious examples
are the clusters (K, B, CPX, H) and (D35, D) which mix
Figure 4 Charge distribution clustering analysis of the HIV-1 subtypes, from the year 2009 consensus sequences and structural
template derived from the gp120 structure with PDB Code 2QAD. The horizontal axis of the dendrogram represents charge similarity
distance. The net charge, global prevalence, coreceptor selectivity and geographies of each subtype are indicated in the figure for each subtype.
N/A denotes that information was not available. Green circles in the branches of the dendrogram denote intersection points between net
charges or infected population. The symbol * refers to the global prevalence of Subtype B which includes the two crystal structural templates
(from 2QAD and 2B4C). The symbol # refers to the global prevalence of Subtype D which includes D and D35, combined.
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Page 9 of 16sequences with +2 and +3 net charges. These observa-
tions suggest that electrostatic clustering is more
detailed, containing more refined charge-related infor-
mation, than sequence clustering.
Clustering and epidemiological data
Figures 2 and 3 also present correlations between the
observed clusters and available epidemiological data on
global prevalence and geographic distribution (year
2004, [21]), and coreceptor selectivity (see below). Sub-
type C is responsible for almost 50% of the infected
population [21]. In the 0 mM data subtype C forms a
cluster together with subtypes A, G, AG, K and B,
accounting together for ~85% of the infected population
(Figure 2). In the 150 mM data subtype C forms a clus-
ter together with subtypes G, AG, K, and B, accounting
together for ~73% of the infected population (subtype
A, corresponding to ~12.3% of the infected population,
Figure 5 Sequence clustering analysis of the HIV-1 subtypes, from the 2009 consensus sequences, based on sequence similarity. The
horizontal axis of the dendrogram represents sequence similarity distance. Global prevalence, coreceptor selectivity and geographic distribution
of each subtype are indicated in the figure. N/A denotes that information was not available. The green box highlights sequences that belong to
Subtype D, while the orange box highlights the two crystal structural templates (from 2QAD and 2B4C), which belong to subtype B. The * refers
to the global prevalence of Subtype B which includes the two crystal structure templates.
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Page 10 of 16moved to a neighboring cluster; Figure 3). Geographic
distributions [21] are also quoted in Figures 2 and 4.
Clustering and structural variability
For many years the intact structure of V3 loop in gp120
was elusive, presumably because of its dynamic charac-
ter. This was alleviated in the crystal structures 2QAD
and 2B4C, which contain multi-protein complexes that
stabilize gp120 and the V3 loop. (In both crystal struc-
tures, the V3 loop is stabilized by contacting the anti-
body components of the multi-protein complex.) The
dynamic character of the V3 loop can be deduced by
observing that its conformation is significantly different
in the two crystal structures, 2QAD and 2B4C (Figure
1), despite the fact that they differ only in two conserva-
tive mutations (Q/N and F/L, Table 1). To assess the
degree that V3 loop dynamics affect its electrostatic
properties, at least using two extreme conformations of
the crystal structures, we performed similar clustering
analyses for electrostatic potentials and charges, using
the 2B4C structure (Additional Files 1, 2 and 3). Electro-
static potential clustering at 0 mM ionic strength (Addi-
tional File 1) is similar to the corresponding data of the
2QAD structure (Figure 2). However, there are differ-
ences in the 150 mM data (Additional File 2 and Figure
3), i.e. +2 subtypes are scrambled within the +3 subtype
clusters. The difference between the 150 mM clustering
data from the two crystal structures originates from
their conformational variability, which results in differ-
ent charge distributions and different enhancements or
cancellations of positive/negative electrostatic potential
distributions. Such differences are not observed in the 0
mM data, because of lack of ionic screening, resulting in
more uniform distribution of the dominant electrostatic
potential (here being positive with the exception of sub-
type O). As in the case of 2QAD, in 2B4C clustering of
spatial distributions of charges does not depict the fine
clustering of electrostatic potential similarities/dissimila-
rities (compare Additional Files 1 and 2). Also, as in the
case of 2QAD, in 2B4C electrostatic clustering is more
detailed, containing refined charge-related information
not present in sequence clustering (compare Additional
Files 1, 2 and 3, and Figure 5).
Influence of homology modeling-derived local flexibility
in calculating electrostatic similarity
Our goal in the studies described above was to produce
and analyze consensus electrostatic potential templates
for the V3 loop structures that capture the average elec-
trostatic characteristics of each consensus sequence. The
consensus sequences were constructed using the high-
est-occurrence amino acid at each V3 loop position,
using several thousands of patient sequences. It should
be understood that amino acid changes to revert a
consensus sequence back to one of the many sequences
used to construct the consensus sequence, would affect
the V3 loop structure at the vicinity of the change(s), as
well as the corresponding electrostatic potential distri-
butions. In addition to sequence variability, the struc-
tural flexibility of the V3 loop indicates dynamic
electrostatic potential distributions around an average
distribution within each subtype.
As mentioned above, with knowledge of the great
structural flexibility of the V3 loop, our strategy was to
perform our analysis twice using the two crystallo-
graphic structures of the V3 loop in order to represent
two extremes of the possible conformations and thereby
accounting for a conformational transition. Additionally,
the analysis based on each crystallographic template was
also performed twice, using ionic strengths correspond-
ing to counterion concentrations of 0 and 150 mM,
resulting in a total of 4 electrostatic similarity analyses
(Figures 2 and 3, and Additional Files 1 and 2). Calcula-
tions at 0 mM ionic strength produce electrostatic
potentials which are more dispersed and smoother, not
as affected by the underlying structure as the 150 mM
potentials, whereas calculations at 150 mM potentials,
in addition to representing physiological conditions, are
more dependent on the underlying structural details.
As a test to assess the effects of local flexibility on the
reliability of our electrostatic potential similarity analy-
sis, we produced 5 homology models for each of the
two V3 loop sequences corresponding to those of the
crystallographic structures. This was made possible with
Modeller, by back-predicting structures using the crys-
tallographic template structures from 2B4C and 2QAD.
When comparing the 5 homology models to their actual
crystallographic template we observe that there is only
slight variation, occurring mainly because of different
side chain rotamers. We performed electrostatic poten-
tial calculations for each set of models at both 0 and
150 mM ionic strength, and computed electrostatic
similarities between the electrostatic potentials of each
of the 5 homology models and the electrostatic potential
of the corresponding template structure. The means and
standard deviations of the calculated electrostatic simila-
rities for the models of each template structure at both
ionic strengths, are shown in Table 2. It is observed that
the electrostatic potentials calculated for the homology
models at 0 mM ionic strength were quite similar to
those of the template structure, since the mean ESD is
~0.1 for both template structures (Table 2). When look-
ing at the dendrogram of Figure 2, which was calculated
at 0 mM ionic strength, we notice that an ESD value of
0.1 is lower than the branches of most clusters, suggest-
ing that such variation is unlikely to significantly affect
the overall clustering. When looking at the 150 mM
data we observe that the mean ESDs are a little higher
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and more detailed electrostatic potentials compared to
those at 0 mM. However, by analyzing the 150 mM
dendrogram in Figure 3, we observe that it is unlikely
that these variations would have a dramatic effect on
clustering either, since once again the 0.4 value is near
the ESD of most pairings. These tests show that the
homology modeling procedure does not exactly repro-
duce the parent potential, but the variations observed
are acceptable given the local flexibility of the small V3
loop peptides. A previous study of the effect of homol-
ogy modeling on electrostatic similarity calculations has
concluded that the variation of electrostatic potentials in
homology models and deviations from electrostatic
potentials corresponding to experimental structures is
comparable to electrostatic potential variations within
NMR ensembles of structures or within molecular
dynamics trajectories [39]. In our case, the consensus
electrostatic potentials resulting from homology model-
ing based on two structural templates and at two ionic
strengths provide electrostatic fingerprints that account
for sequence variability and structural flexibility. These
fingerprints can be used to understand the binding
properties of each subtype and to predict the classifica-
tion of new sequences.
Sequence, glycosylation, and charge rules for coreceptor
selectivity
Because there are no X4-tropic consensus sequences in
the 2009 data, with the exception of the non-consensus
sequence of crystal structure 2B4C (Figure 2), we
resorted to sequence, glycosylation, and charge rules to
present a predictive scheme for coreceptor selectivity.
The coreceptor selection by HIV-1 is known to be influ-
enced by the charge of the V3 loop, amino acid types at
specific locations, and the presence of glycosylation
sites. Differences in coreceptor selection by HIV-1 sub-
types have been shown by experimental studies
[12,20,70,71], and computationally predicted [72-76],
although the effectiveness of the predictions is not con-
clusive. Based on previous studies and renewed thinking
with respect to net charge, we used several criteria for
coreceptor selection, shown in Figure 6. If the glycosyla-
tion motif (N
6X
7T
8|S
8X
9,w h e r e×≠ Pro and N being
the glycosylation site) is absent from the V3 loop
sequence, the virus will show preference toward CXCR4
as coreceptor. Experimental studies have demonstrated
that loss of glycosylation sites in the V3 loop is asso-
ciated with selection of CXCR4 [70,71]. If the N
6X
7T
8|
S
8X
9 motif is present, the coreceptor selection will be
influenced by the amino acids at positions 11, 24, and
25 (of the “11/24/25” rule); if any of these amino acids
are not positively charged, the virus will show prefer-
ence toward CCR5 [12]. We propose that if the
N
6X
7T
8|S
8X
9 glycosylation motif is present and any of
the amino acids at positions 11, 24 and 25 are positively
charged, coreceptor preference will be governed by the
net charge of the V3 loop sequence. If the net charge of
the V3 loop is > 5, the virus will show preference
toward CXCR4. Experimental studies have suggested
that a high charge in the V3 is associated with loss of
the glycosylation site and utilization of CXCR4 [71];
however if the net charge of the V3 loop is ≤ 5, the
virus will show preference for CCR5. Coreceptor selec-
tion will be affected by the presence and number of
acidic chemical groups, like sialic acids, in the glycans.
Typically, the glycans can have up to four sialic acids,
each adding one negative charge to the loop [77]. Thus,
the presence of glycans may reduce the net charge of
sequences with amino acid net charge of > 5 to ≤ 5.
This means that a sequence classified as X4-tropic
based on amino acid net charge, can be reclassified as
R5-tropic using net charge based on amino acids and
glycans. Because the number of sialic acids is not
known, sequences falling in this category are classified
as X4-, R5-or dual-tropic (Figure 6). It should be noted
that at lower V3 loop net charges (+3, +4), no effect was
seen with alteration of N-glycosylation [71]. In our
interpretation, if glycosylation takes place, it lowers the
net positive net charge even more and thus the
sequence remains within the R5-tropic definition
according to the scheme of Figure 6. We have tested the
flow chart of Figure 6 with experimental data for a ser-
ies of R5- and X4-tropic sequences [70,71] and found
consistency between the predicted and experimentally-
derived tropisms. All consensus sequences studied here,
and the sequence of 2QAD crystal structure, are R5-tro-
p i ca c c o r d i n gt ot h es c h e m eo fF i g u r e6 ,p e r h a p s
because CCR5 is the first viral preference for the asymp-
tomatic cell infection prior to switching to CXCR4, and
an insufficient number of X4-tropic sequences is avail-
able for consensus. However, individual patients infected
w i t hX 4 - t r o p i cv i r u s e so ft h ea f o r e m e n t i o n e dd a t ao f
Table 2 Comparisons of ESDs of multiple V3 loop
homology models.
Structural Template Sequence
(Ionic Strength)
Mean ESD SD
2B4C (0 mM) 0.13 0.04
2QAD (0 mM) 0.10 0.02
2B4C (150 mM) 0.43 0.09
2QAD (150 mM) 0.35 0.06
Each Table entry presents the mean ESD and standard deviation (SD) for 5
homology models generated using Modeller. The modeled structures were
constructed by back-prediction using the crystallographic template structures
and their sequences (from 2B4C and 2QAD). Electrostatic potentials for each
family of 5 homology models were calculated at 0 and 150 mM ionic
strength. The goal of this comparison is to assess the effect of structural
variability, observed within each family of 5 homology models, on the
calculated ESDs.
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Page 12 of 16Refs. [70,71] have V3 loop sequences which are classi-
fied as X4-tropic using the scheme of Figure 6. It is
likely that as CCR5 receptors are being depleted, the
virus evolves through mutational pressure in increasing
the positive charge of the V3 loop for more efficient
recognition of cells with CXCR4 receptors. This may be
because the N-terminal domain of CXCR4 has smaller
negative net charge (and electrostatic potential) than
Figure 6 Flow chart for prediction of HIV-1 coreceptor selectivity based on V3 loop sequence and charge properties. This scheme is
based on the presence of the N
6X
7T
8|S
8X
9 sequence/glycosylation motif [71], the presence of a positive amino acid at sequence positions 11, 24,
and 25 (the 11/24/25 rule) [12], and the net charge. The presence of acidic chemical groups in the glycosylation patterns (e.g., sialic acids) could
affect the charge of the V3 loop, thus affecting the coreceptor selection. Therefore, the virus can use CXCR4, CCR5 or both receptors for cell
entry (dual tropic).
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Page 13 of 16that of CCR5, thus requiring larger positive net charge
(and electrostatic potential) in the V3 loop for
interaction.
Conclusions
In overview, we have performed clustering analysis to
distinguish the electrostatic contributions to recognition
and binding for the 2009 consensus sequences of the V3
loop of HIV-1 gp120. Our analysis is based on a two-
step association model, which distinguishes recognition
(formation of a weak nonspecific encounter complex)
from binding (formation of a strong specific final com-
plex). Clustering of spatial distributions of electrostatic
potentials (in the protein exterior and interior) depicts
the significance of long-range electrostatic interactions
to the recognition of the V3 loop with extracellular
loops of CCR5/CXCR4. Clustering of spatial distribu-
tions of charges (in the protein surface and interior)
provides information on the significance of individual
charges in short-range electrostatic interactions to the
binding of the V3 loop to CCR5/CXCR4. This analysis
clusters the V3 loop consensus sequences according to
the similarities/dissimilarities of their electrostatic
potentials and charges. Although clustering of charges
and electrostatic potentials share similarities, they are in
general different with the former emphasizing local
effects and the latter emphasizing macroscopic effects.
In addition, electrostatic potentials are sensitive to ionic
strength effects, which is not the case for charges. This
type of clustering, at the level of the specific physico-
chemical property, is not depicted in the widely used
clustering of sequences, although conceptually
sequences are closer to charges as they contain align-
ments of amino acids with specific physicochemical
properties, including charge. The major advantage of
charges and electrostatic potentials is that they contain
information of spatial physicochemical details, which is
not present in sequences.
Clustering of charges and electrostatic potentials pro-
vides a refined analysis, compared to clustering of
sequences, for proteins in which electrostatics is the
driving force for association, as is the case of the gp120
V3 loop. The clustering of electrostatic potentials is of
particular importance for inhibitor design and eventually
for anti-HIV drug design. As we have shown previously
for the case of short peptides derived from the V3 loop
of gp120, scrambling of charges within the sequence
does not affect binding to an N-terminal peptide of
CCR5 or inhibition in infectivity assays [18,19]. The
magnitude of the electrostatic potential was in general
proportional to net charge for highly positively charged
V3 loop-derived peptides (with additive electrostatic
potential property), and correlated well with binding
and inhibition data. In the case of the flexible and
variable V3 loop, targeting the recognition process, and
specifically targeting the bulk physiochemical property
of the electrostatic potential, may be an efficient avenue
for drug design. This may be possible as long as the spa-
tial distribution of the electrostatic potential remains
largely invariable despite the dynamic character of the
V3 loop. In the present study, we provide a database of
electrostatic property classification for consensus
sequences of gp120, at the V3 loop level, for the time
point of year 2009. We also provide correlations with
prevalence and geographic distribution and coreceptor
selectivity. Coreceptor selectivity depends on the specific
N
6X
7T
8|S
8X
9 sequence motif, the specific positive
charge location according to the 11/24/25 rule, and the
overall charge and electrostatic potential distribution
mediated not only by charged amino acid side chains,
but also by glycosylation patterns. For this reason, an
elaborate scheme for determining coreceptor selectivity
is presented.
Additional material
Additional File 1: Electrostatic potential clustering analysis of the
HIV-1 subtypes, from the 2009 consensus, using the structure with
PDB Code 2B4Cas template. The horizontal axis of the dendrogram
represents electrostatic similarity distance. Electrostatic potentials were
calculated using ionic strength corresponding to 0 mM salt
concentration. Isopotential contours are presented in 4 different
orientations, corresponding to rotations about the vertical axis.
Isopotential contours are plotted at ± 1 kBT/e, with blue and red
corresponding to positive and negative electrostatic potentials,
respectively. The net charge, global prevalence, coreceptor selectivity,
and geographic distribution are indicated in the figure for each subtype.
N/A denotes that information was not available. The orange boxes
highlight clusters with HIV-1 subtypes that have similar electrostatic
potential. Green circles in the branches of the dendrogram denote
intersection points between net charges or infected population. The *
refers to the global prevalence of subtype B, which include the two
structural templates (2B4C and 2QAD). The # refers to the global
prevalence of subtype D, which include D and D35.
Additional File 2: Electrostatic potential clustering analysis of the
HIV-1 subtypes, from the 2009 consensus, using the structure with
PDB Code 2B4Cas template. The horizontal axis of the dendrogram
represents electrostatic similarity distance. Electrostatic potentials were
calculated using ionic strength corresponding to 150 mM salt
concentration. Isopotential contours are presented in 4 different
orientations, corresponding to rotations about the vertical axis.
Isopotential contours are plotted at ± 1 kBT/e, with blue and red
corresponding to positive and negative electrostatic potentials,
respectively. The orange box highlight clusters with HIV-1 subtypes that
have similar electrostatic potential and same charge. Green circles in the
branches of the dendrogram denote intersection points between net
charges or infected population.
Additional File 3: Charge distribution clustering analysis of the HIV-
1 subtypes, from the 2009 consensus, using the structure with PDB
Code 2B4Cas template. The horizontal axis of the dendrogram
represents charge similarity distance. The net charge, global prevalence,
coreceptor selectivity and geographical distribution are indicated in the
figure for each subtype. N/A denotes that information was not available.
Green circles in the branches of the dendrogram denote intersection
points between net charges or infected population. The * refers to the
global prevalence of subtype B, which include the two structural
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Page 14 of 16templates (2B4C and 2QAD). The # refers to the global prevalence of
subtype D, which include D and D35.
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